title: Why should older adults receive the shingles vaccine?
abstract: This article seeks to educate health care providers in understanding the need for immunization of older adults with the new herpes zoster vaccine, Zostavax(®). Herpes zoster (shingles) is a painful and disabling condition that can result in significant morbidity, loss of productivity, and decrease in quality of life. Herpes zoster is a reactivation of the varicella zoster virus, the same virus that causes chicken pox. Anyone who has had chickenpox can get shingles. Evidence found in the literature demonstrates that the vaccine prevents shingles in approximately half of adults 60 and older.
authors.affiliation: Texas Tech Health Sciences Center, Marble Falls, TX, USA. laneigh.harkness@ttuhsc.edu
authors.forename: Turna Laneigh
authors.initials: TL
authors.lastname: Harkness
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006266:Health Education; D006562:Herpes Zoster / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D019458:Insurance Coverage; D006278:Medicare; D008875:Middle Aged; D051474:Neuralgia, Postherpetic / Q000517:prevention & control; D014481:United States; D014611:Vaccination / Q000191:economics
chemical_list: D053061:Herpes Zoster Vaccine